US3534017A
(en)
|
1967-03-14 |
1970-10-13 |
Kyowa Hakko Kogyo Kk |
Process for the preparation of nucleoside-5'-diphosphates and triphosphates and mono- and oligo-nucleotidyl-nucleoside-5'-diphosphates and triphosphates
|
US4210746A
(en)
|
1978-08-10 |
1980-07-01 |
National Research Development Corporation |
Nucleotide inhibitor of protein synthesis
|
US4285605A
(en)
|
1979-07-02 |
1981-08-25 |
International Business Machines Corporation |
Escapement mechanism and backspace mechanism for a moving paper carriage typewriter having dual pitch capability
|
FR2471785A1
(fr)
|
1979-12-21 |
1981-06-26 |
Fabre Sa Pierre |
Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
|
DE3023787A1
(de)
|
1980-06-25 |
1982-01-21 |
Studiengesellschaft Kohle mbH, 4330 Mülheim |
Verfahren zur erhoehung der inkorporation und der expression von genetischem material in die kerne von intakten zellen mit hilfe von liposomen
|
EP0081099A3
(en)
|
1981-12-04 |
1983-08-10 |
Sloan-Kettering Institute For Cancer Research |
Capped oligonucleotide anti-viral agents
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US5194428A
(en)
|
1986-05-23 |
1993-03-16 |
Worcester Foundation For Experimental Biology |
Inhibition of influenza virus replication by oligonucleotide phosphorothioates
|
US5264423A
(en)
|
1987-03-25 |
1993-11-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors for replication of retroviruses and for the expression of oncogene products
|
JPH04501052A
(ja)
|
1988-02-26 |
1992-02-27 |
ザ・ウスター・フアウンデーシヨン・フオー・バイオメデイカル・リサーチ |
外来性オリゴヌクレオチドによるhtlv―3の抑制
|
JP2976436B2
(ja)
|
1988-04-27 |
1999-11-10 |
味の素株式会社 |
新規オリゴリボヌクレオチド誘導体及び抗ウイルス剤への使用
|
DE68929304T2
(de)
|
1988-04-27 |
2002-04-25 |
Isis Pharmaceutical Inc |
Oligoribonukleotid-Derivate und Verwendung davon als Antiviral-Arzneimittel
|
DE3907562A1
(de)
|
1989-03-09 |
1990-09-13 |
Bayer Ag |
Antisense-oligonukleotide zur inhibierung der transaktivatorzielsequenz (tar) und der synthese des transaktivatorproteins (tat) aus hiv-1 und deren verwendung
|
JPH04507402A
(ja)
|
1989-05-18 |
1992-12-24 |
マイクロプローブ・コーポレーション |
架橋オリゴヌクレオチド
|
US5134066A
(en)
|
1989-08-29 |
1992-07-28 |
Monsanto Company |
Improved probes using nucleosides containing 3-dezauracil analogs
|
EP0800830A3
(en)
|
1989-11-03 |
1999-03-17 |
Vanderbilt University |
Method of in vivo delivery of functioning foreign genes
|
US5149797A
(en)
|
1990-02-15 |
1992-09-22 |
The Worcester Foundation For Experimental Biology |
Method of site-specific alteration of rna and production of encoded polypeptides
|
EP0523140A4
(en)
|
1990-03-21 |
1993-06-16 |
Isis Pharmaceuticals, Inc. |
Reagents and methods for modulating gene expression through rna mimicry
|
US5292875A
(en)
|
1990-04-20 |
1994-03-08 |
Lynx Therapeutics, Inc. |
Method of synthesizing sulfurized oligonucleotide analogs
|
US5166195A
(en)
|
1990-05-11 |
1992-11-24 |
Isis Pharmaceuticals, Inc. |
Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
|
IL99069A
(en)
|
1990-08-09 |
1998-08-16 |
Genta Inc |
Methyphosphonate oligonucleotides associated with psoralen
|
KR970005274B1
(ko)
|
1990-08-14 |
1997-04-15 |
아이시스 파마슈티칼스, 인코포레이티드 |
안티센스 올리고뉴클레오티드에 의한 a형 인플루엔자 바이러스, 안 아아보스트레인(ann arbor strain) h2n2의 억제
|
US5271941A
(en)
|
1990-11-02 |
1993-12-21 |
Cho Chung Yoon S |
Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases
|
DE4110085A1
(de)
|
1991-03-27 |
1992-10-01 |
Boehringer Ingelheim Int |
2'-o-alkyl-oligoribonukleotide, verfahren zu deren herstellung und deren verwendung als antisense-oligonukleotide
|
CA2105864A1
(en)
|
1991-03-27 |
1992-09-28 |
Eric T. Kool |
Single-stranded, circular oligonucleotides
|
US5646267A
(en)
|
1991-08-05 |
1997-07-08 |
Polish Academy Of Sciences |
Method of making oligonucleotides and oligonucleotide analogs using phospholanes and enantiomerically resolved phospholane analogues
|
US7119184B2
(en)
|
1991-08-12 |
2006-10-10 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having A-DNA form and B-DNA form conformational geometry
|
US6369209B1
(en)
|
1999-05-03 |
2002-04-09 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having A-DNA form and B-DNA form conformational geometry
|
DE69232699T2
(de)
|
1991-10-15 |
2003-02-06 |
Isis Pharmaceutical Inc |
Über chirale phosphoratome gebundene oligonukleotide
|
NZ244820A
(en)
|
1991-10-25 |
1994-01-26 |
Isis Pharmaceuticals Inc |
Oligonucleotide inhibitor of epstein-barr virus.
|
FR2685346B1
(fr)
|
1991-12-18 |
1994-02-11 |
Cis Bio International |
Procede de preparation d'arn double-brin, et ses applications.
|
US5644048A
(en)
|
1992-01-10 |
1997-07-01 |
Isis Pharmaceuticals, Inc. |
Process for preparing phosphorothioate oligonucleotides
|
EP0642589A4
(en)
|
1992-05-11 |
1997-05-21 |
Ribozyme Pharm Inc |
METHOD AND REAGENT TO INHIBIT VIRAL REPLICATION.
|
US5606049A
(en)
|
1992-06-03 |
1997-02-25 |
Genta Incorporated |
Method of preparing 2'-O-methyl cytidine monomers useful in oligomer synthesis
|
US5652355A
(en)
|
1992-07-23 |
1997-07-29 |
Worcester Foundation For Experimental Biology |
Hybrid oligonucleotide phosphorothioates
|
US6346614B1
(en)
|
1992-07-23 |
2002-02-12 |
Hybridon, Inc. |
Hybrid oligonucleotide phosphorothioates
|
TW244371B
(es)
|
1992-07-23 |
1995-04-01 |
Tri Clover Inc |
|
AU4684993A
(en)
|
1992-07-23 |
1994-02-14 |
Isis Pharmaceuticals, Inc. |
Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
|
IL108206A0
(en)
|
1993-01-06 |
1994-04-12 |
Univ Johns Hopkins |
Oligomers having improved stability at acid ph
|
NZ262254A
(en)
|
1993-01-25 |
1997-10-24 |
Hybridon Inc |
Oligonucleotide analogue containing a ribonucleotide alkylphosphon(ate or thioate), gene repression
|
AU6632094A
(en)
|
1993-04-19 |
1994-11-08 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
FR2705099B1
(fr)
|
1993-05-12 |
1995-08-04 |
Centre Nat Rech Scient |
Oligonucléotides phosphorothioates triesters et procédé de préparation.
|
WO1995003406A2
(en)
|
1993-07-19 |
1995-02-02 |
Gen-Probe Incorporated |
Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens
|
JPH0799976A
(ja)
|
1993-09-30 |
1995-04-18 |
Takeda Chem Ind Ltd |
修飾オリゴヌクレオチド
|
US5801235A
(en)
|
1994-05-25 |
1998-09-01 |
Hybridon, Inc. |
Oligonucleotides with anti-cytomegalovirus activity
|
EP0760666A1
(en)
|
1994-05-27 |
1997-03-12 |
HYBRIDON, Inc. |
Use of oligonucleotide phosphorothioate for depleting complement and for reducing blood pressure
|
US5866699A
(en)
|
1994-07-18 |
1999-02-02 |
Hybridon, Inc. |
Oligonucleotides with anti-MDR-1 gene activity
|
AU3675195A
(en)
|
1994-09-07 |
1996-03-27 |
Hybridon, Inc. |
Oligonucleotide prodrugs
|
US5591721A
(en)
|
1994-10-25 |
1997-01-07 |
Hybridon, Inc. |
Method of down-regulating gene expression
|
JPH08154687A
(ja)
|
1994-12-12 |
1996-06-18 |
Yamanouchi Pharmaceut Co Ltd |
アンチセンスオリゴヌクレオチド及び抗ウイルス剤
|
AU4412096A
(en)
|
1994-12-13 |
1996-07-03 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses
|
EP0807171A1
(en)
|
1994-12-22 |
1997-11-19 |
HYBRIDON, Inc. |
Synthesis of stereospecific oligonucleotide phosphorothioates
|
US6111095A
(en)
|
1995-06-07 |
2000-08-29 |
Merck & Co., Inc. |
Capped synthetic RNA, analogs, and aptamers
|
GB9511720D0
(en)
|
1995-06-09 |
1995-08-02 |
Isis Innovation |
Oligonucleotide phosphorylation method and products
|
US20040234999A1
(en)
|
1996-04-02 |
2004-11-25 |
Farrar Gwenyth Jane |
Genetic suppression and replacement
|
US6127535A
(en)
|
1997-11-05 |
2000-10-03 |
Ribozyme Pharmaceuticals, Inc. |
Nucleoside triphosphates and their incorporation into oligonucleotides
|
EP1626086A2
(en)
|
1998-04-20 |
2006-02-15 |
Ribozyme Pharmaceuticals, Inc. |
Double-stranded nucleic acid molecules with novel chemical compositions capable of modulating gene expression
|
EP1493818A3
(en)
|
1998-04-29 |
2006-02-15 |
Ribozyme Pharmaceuticals, Inc. |
Nucleoside triphosphates and their incorporation into ribozymes
|
WO1999055857A2
(en)
|
1998-04-29 |
1999-11-04 |
Ribozyme Pharmaceuticals, Inc. |
Nucleoside triphosphates and their incorporation into ribozymes
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
US6344323B1
(en)
|
1998-09-16 |
2002-02-05 |
Vitagenix, Inc. |
Compositions and methods for inhibiting cox-2 expression and treating cox-2 associated disorders by using cox-2 antisense oligonucleotides
|
WO2001016312A2
(en)
|
1999-08-31 |
2001-03-08 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid based modulators of gene expression
|
MXPA02003059A
(es)
|
1999-09-27 |
2002-09-30 |
Univ Iowa Res Found |
Metodos relacionados con interferon inducido por acido nucleico inmunoestabilizador.
|
US20020028784A1
(en)
|
2000-03-10 |
2002-03-07 |
Nest Gary Van |
Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
|
DE10013600A1
(de)
|
2000-03-18 |
2002-01-10 |
Aventis Res & Tech Gmbh & Co |
Reaktive Monomere für die Oligonucleotid- und Polynucleotidsynthese, modifizierte Oligonucleotide und Polynucleotiden und ein Verfahren zu deren Herstellung
|
US6686461B1
(en)
|
2000-03-22 |
2004-02-03 |
Solulink Bioscience, Inc. |
Triphosphate oligonucleotide modification reagents and uses thereof
|
US20030077609A1
(en)
|
2001-03-25 |
2003-04-24 |
Jakobsen Mogens Havsteen |
Modified oligonucleotides and uses thereof
|
WO2003008432A1
(en)
|
2001-07-16 |
2003-01-30 |
Isis Pharmaceuticals, Inc. |
Process for the preparation of alpha modified nucleoside triphosphates and compounds therefrom
|
AU2002329667A1
(en)
|
2001-07-30 |
2003-02-17 |
Uta Griesenbach |
Specific inhibition of gene expression by small double stranded rnas
|
FR2832154B1
(fr)
|
2001-11-09 |
2007-03-16 |
Centre Nat Rech Scient |
Oligonucleotides inhibiteurs et leur utilisation pour reprimer specifiquement un gene
|
US20030203868A1
(en)
|
2002-02-06 |
2003-10-30 |
Bushman Frederic D. |
Inhibition of pathogen replication by RNA interference
|
US7285658B2
(en)
|
2002-02-28 |
2007-10-23 |
Biota, Inc. |
Nucleotide mimics and their prodrugs
|
AU2003218181A1
(en)
|
2002-03-15 |
2003-09-29 |
Multicell Immunotherapeutics, Inc. |
Immunostimulatory double stranded RNA and methods of inducing, enhancing or modulating the immune response
|
EP1499187B1
(en)
|
2002-04-04 |
2015-06-17 |
Zoetis Belgium S.A. |
Immunostimulatory g,u-containing oligoribonucleotides
|
JP5578388B2
(ja)
|
2002-04-18 |
2014-08-27 |
オプコ ファーマシューティカルズ、エルエルシー |
中枢神経システム及び/若しくは眼の細胞及び組織中の遺伝子の特異的阻害のための手段と方法
|
WO2003091433A1
(fr)
|
2002-04-26 |
2003-11-06 |
National Institute Of Advanced Industrial Science And Technology |
Systeme d'expression pour molecule d'arn a tige-boucle ayant un effet d'arni
|
CA2388049A1
(en)
|
2002-05-30 |
2003-11-30 |
Immunotech S.A. |
Immunostimulatory oligonucleotides and uses thereof
|
CN1685063B
(zh)
|
2002-08-12 |
2011-12-21 |
新英格兰生物实验室公司 |
与基因沉默相关的方法和组合物
|
US7109316B2
(en)
|
2002-08-23 |
2006-09-19 |
Ce Healthcare Bio-Sciences Corp. |
Oligonucleotide tagged nucleoside triphosphates (OTNTPs) for genetic analysis
|
US20110098200A1
(en)
|
2002-09-04 |
2011-04-28 |
Johnson & Johnson Research Pty Ltd |
Methods using dsdna to mediate rna interference (rnai)
|
ES2359055T3
(es)
|
2002-09-11 |
2011-05-18 |
Genentech, Inc. |
Composiciones y métodos para el diagnóstico y el tratamiento de tumores.
|
US7250496B2
(en)
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
EP1560931B1
(en)
|
2002-11-14 |
2011-07-27 |
Dharmacon, Inc. |
Functional and hyperfunctional sirna
|
US20130130231A1
(en)
|
2002-11-26 |
2013-05-23 |
Isaac Bentwich |
Bioinformatically detectable group of novel viral regulatory genes and uses thereof
|
US7696334B1
(en)
|
2002-12-05 |
2010-04-13 |
Rosetta Genomics, Ltd. |
Bioinformatically detectable human herpesvirus 5 regulatory gene
|
US7217807B2
(en)
|
2002-11-26 |
2007-05-15 |
Rosetta Genomics Ltd |
Bioinformatically detectable group of novel HIV regulatory genes and uses thereof
|
PT1581812E
(pt)
|
2003-01-06 |
2008-09-22 |
Wyeth Corp |
Composições e métodos para diagnóstico e tratamento de cancros do cólon
|
WO2004074441A2
(en)
|
2003-02-19 |
2004-09-02 |
Government Of The United States Of America Represented By The Secretary Department Of Health And Human Services |
Amplification or overexpression of mll septin-like fusion (msf) and septin9 and methods related thereto
|
CN1176937C
(zh)
|
2003-02-21 |
2004-11-24 |
复旦大学附属中山医院 |
一种双链rna及其用途
|
US20040261149A1
(en)
|
2003-02-24 |
2004-12-23 |
Fauquet Claude M. |
siRNA-mediated inhibition of gene expression in plant cells
|
WO2004080425A2
(en)
|
2003-03-12 |
2004-09-23 |
Vasgene Therapeutics, Inc. |
Polypeptide compounds for inhibiting angiogenesis and tumor growth
|
US7381410B2
(en)
|
2003-03-12 |
2008-06-03 |
Vasgene Therapeutics, Inc. |
Polypeptide compounds for inhibiting angiogenesis and tumor growth
|
WO2004083430A2
(en)
|
2003-03-21 |
2004-09-30 |
Santaris Pharma A/S |
SHORT INTERFERING RNA (siRNA) ANALOGUES
|
US20040220130A1
(en)
|
2003-03-24 |
2004-11-04 |
Robbins Paul D. |
Compact synthetic expression vector comprising double-stranded DNA molecules and methods of use thereof
|
US8969543B2
(en)
|
2003-04-03 |
2015-03-03 |
Bioneer Corporation |
SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof
|
US20050042641A1
(en)
|
2003-05-27 |
2005-02-24 |
Cold Spring Harbor Laboratory |
In vivo high throughput selection of RNAi probes
|
US20050059044A1
(en)
|
2003-06-03 |
2005-03-17 |
Graham Michael Wayne |
Double-stranded nucleic acid
|
JPWO2004108921A1
(ja)
|
2003-06-06 |
2006-07-20 |
大日本住友製薬株式会社 |
核酸導入法
|
CA2528597C
(en)
|
2003-06-11 |
2014-08-05 |
Hybridon, Inc. |
Stabilized immunomodulatory oligonucleotides
|
FR2857013B1
(fr)
|
2003-07-02 |
2005-09-30 |
Commissariat Energie Atomique |
Petits arn interferents specifiques des sous-unites alpha, alpha prime et beta de la proteine kinase ck2 et leurs applications
|
WO2005062854A2
(en)
|
2003-12-19 |
2005-07-14 |
University Of Cincinnati |
Polyamides for nucleic acid delivery
|
WO2005076979A2
(en)
|
2004-02-06 |
2005-08-25 |
Wyeth |
Diagnosis and therapeutics for cancer
|
US20050182005A1
(en)
|
2004-02-13 |
2005-08-18 |
Tuschl Thomas H. |
Anti-microRNA oligonucleotide molecules
|
US20070265220A1
(en)
|
2004-03-15 |
2007-11-15 |
City Of Hope |
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
|
EP2514758B2
(en)
|
2004-03-15 |
2021-06-23 |
City of Hope |
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
|
US20060035815A1
(en)
|
2004-05-04 |
2006-02-16 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical compositions for delivery of ribonucleic acid to a cell
|
MXPA06012605A
(es)
|
2004-05-04 |
2006-12-15 |
Nastech Pharm Co |
Composiciones y metodos para mejorar el suministro de acidos nucleicos en celulas y para modificar la expresion de genes objetivo en celulas.
|
US20070218079A1
(en)
|
2004-05-12 |
2007-09-20 |
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. |
Method to induce rnai in prokaryotic organisms
|
EP1773857A4
(en)
|
2004-07-02 |
2009-05-13 |
Protiva Biotherapeutics Inc |
THE IMMUNE SYSTEM STIMULATING SIRNA MOLECULES AND APPLICATIONS THEREOF
|
JPWO2006016574A1
(ja)
|
2004-08-12 |
2008-05-01 |
国立大学法人 熊本大学 |
RNAiを利用した抗腫瘍剤
|
EP1657306B1
(en)
|
2004-11-16 |
2011-04-13 |
QIAGEN GmbH |
Gene silencing using sense DNA and antisense RNA hybrid constructs coupled to peptides facilitating the uptake into cells
|
CA2589406A1
(en)
|
2004-12-09 |
2006-06-15 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering rnas
|
WO2006074400A2
(en)
|
2005-01-07 |
2006-07-13 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Method to trigger rna interference
|
WO2006078646A2
(en)
|
2005-01-18 |
2006-07-27 |
Caltagirone Gaetano T |
A class of supramolecular drug molecules and methods of identification and use thereof
|
US20060178334A1
(en)
|
2005-02-04 |
2006-08-10 |
City Of Hope |
Double-stranded and single-stranded RNA molecules with 5 ' triphosphates and their use for inducing interferon
|
JP4972538B2
(ja)
|
2005-02-07 |
2012-07-11 |
武田薬品工業株式会社 |
神経変性疾患の予防・治療剤
|
JP4645234B2
(ja)
|
2005-03-03 |
2011-03-09 |
和光純薬工業株式会社 |
架橋剤、それを用いた架橋方法、遺伝子発現調節方法および遺伝子機能調査方法
|
AU2006230436B2
(en)
|
2005-03-31 |
2011-11-24 |
Calando Pharmaceuticals, Inc. |
Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
|
BRPI0610499A2
(pt)
|
2005-04-12 |
2010-06-22 |
Intradigm Corp |
moléculas de ácido nucléico , composições e usos das referidas moléculas
|
US7893244B2
(en)
|
2005-04-12 |
2011-02-22 |
Intradigm Corporation |
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
|
US20070066521A1
(en)
|
2005-04-13 |
2007-03-22 |
Fauquet Claude M |
Short RNA-binding proteins
|
WO2006119643A1
(en)
|
2005-05-12 |
2006-11-16 |
Replicor Inc. |
Anti-ocular angiogenesis molecules and their uses
|
WO2006122409A1
(en)
|
2005-05-16 |
2006-11-23 |
Replicor Inc. |
Antimicrobial molecules and their uses
|
JP5371424B2
(ja)
|
2005-06-01 |
2013-12-18 |
ポリプラス トランスフェクション エスアー |
Rna干渉のためのオリゴヌクレオチドおよびその生物学的適用
|
WO2006130949A1
(en)
|
2005-06-08 |
2006-12-14 |
Replicor Inc. |
Anti amyloid-related disease molecules and their uses
|
EP1915448B1
(en)
|
2005-07-07 |
2013-09-04 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Nucleic acid agents for downregulating h19, and methods of using same
|
KR100883471B1
(ko)
|
2005-08-17 |
2009-02-16 |
(주)바이오니아 |
siRNA의 세포내 전달을 위한 siRNA와 친수성 고분자 간의접합체 및 그의 제조방법
|
JP2009507852A
(ja)
|
2005-09-08 |
2009-02-26 |
エムディーアールエヌエー,インコーポレイテッド |
リボ核酸の細胞への送達用医薬組成物
|
EP1764107A1
(en)
|
2005-09-14 |
2007-03-21 |
Gunther Hartmann |
Compositions comprising immunostimulatory RNA oligonucleotides and methods for producing said RNA oligonucleotides
|
US8076068B2
(en)
|
2005-09-14 |
2011-12-13 |
Gunther Hartmann |
Method for determining immunostimulatory activity of RNA oligonucleotides
|
WO2007038788A2
(en)
|
2005-09-29 |
2007-04-05 |
The Cleveland Clinic Foundation |
Small interfering rnas as non-specific drugs
|
AU2006308765B2
(en)
|
2005-11-02 |
2013-09-05 |
Arbutus Biopharma Corporation |
Modified siRNA molecules and uses thereof
|
EP2431467A3
(en)
|
2005-11-17 |
2012-05-02 |
Board Of Regents, The University Of Texas |
Modulation of gene expression by oligomers targeted to chromosomal DNA
|
NZ602571A
(en)
|
2005-12-12 |
2014-03-28 |
Univ North Carolina |
Micrornas that regulate muscle cell proliferation and differentiation
|
WO2007080457A2
(en)
|
2005-12-30 |
2007-07-19 |
Institut Gustave Roussy |
Use of inhibitors of scinderin and/or of ephrin-a1 for treating tumors
|
EP2004141A2
(en)
|
2006-03-17 |
2008-12-24 |
Novosom AG |
An efficient method for loading amphoteric liposomes with nucleic acid active substances
|
ES2564303T3
(es)
|
2006-04-07 |
2016-03-21 |
Idera Pharmaceuticals, Inc. |
Compuestos de ARN inmunomodulador estabilizado (SIMRA) para TLR7 y TLR8
|
DE602007013223D1
(de)
|
2006-06-01 |
2011-04-28 |
Trilink Biotechnologies San Diego |
Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation
|
US20080091005A1
(en)
|
2006-07-20 |
2008-04-17 |
Visigen Biotechnologies, Inc. |
Modified nucleotides, methods for making and using same
|
WO2008014979A2
(en)
|
2006-07-31 |
2008-02-07 |
Curevac Gmbh |
NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
|
EP1920775B1
(en)
|
2006-10-10 |
2012-12-19 |
Gunther Prof. Dr. Hartmann |
5'Triphosphate oligonucleotide induces anti-viral response
|
ES2647452T3
(es)
|
2006-08-08 |
2017-12-21 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Estructura y uso de oligonucleótidos 5' fosfato
|
EP2069500B1
(en)
|
2006-10-04 |
2014-09-24 |
Centre National De La Recherche Scientifique (Cnrs) |
Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof
|
WO2008045576A2
(en)
|
2006-10-12 |
2008-04-17 |
Yijia Liu |
Compositions and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases
|
CN101190944A
(zh)
|
2006-12-01 |
2008-06-04 |
北京诺赛基因组研究中心有限公司 |
人类新细胞因子及其用途
|
JP2010512786A
(ja)
|
2006-12-21 |
2010-04-30 |
イントラダイム コーポレイション |
ガンを処置するための抑制性ポリヌクレオチドの組成物および方法
|
US20130005028A1
(en)
|
2006-12-21 |
2013-01-03 |
Smith Larry R |
Activation of RIG-I Pathway
|
US7858772B2
(en)
|
2006-12-22 |
2010-12-28 |
Roche Molecular Systems, Inc. |
Compounds and methods for synthesis and purification of oligonucleotides
|
CA2675967A1
(en)
|
2007-01-16 |
2008-07-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M |
Nucleic acid constructs and methods for specific silencing of h19
|
US9249423B2
(en)
|
2007-02-02 |
2016-02-02 |
Yale University |
Method of de-differentiating and re-differentiating somatic cells using RNA
|
WO2008099396A1
(en)
|
2007-02-15 |
2008-08-21 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Use of h19-silencing nucleic acid agents for treating restenosis
|
WO2008102728A1
(ja)
|
2007-02-19 |
2008-08-28 |
Kyoto University |
核酸導入用導電性基板および核酸導入方法
|
MY173854A
(en)
|
2007-03-13 |
2020-02-25 |
Malaysian Palm Oil Board |
Expression regulatory elements
|
EP2134740A2
(en)
|
2007-04-09 |
2009-12-23 |
Chimeros, Inc. |
Self-assembling nanoparticle drug delivery system
|
CN101088565A
(zh)
|
2007-04-17 |
2007-12-19 |
华东师范大学 |
miRNA-34a的用途
|
CN101289486B
(zh)
*
|
2007-04-18 |
2012-05-30 |
上海吉凯基因化学技术有限公司 |
一种合成rna单体的方法
|
WO2008134593A1
(en)
|
2007-04-25 |
2008-11-06 |
President And Fellows Of Harvard College |
Molecular circuits
|
CN101889086B
(zh)
|
2007-05-01 |
2014-07-02 |
桑塔里斯制药公司 |
Tnf超家族受体的剪接转换寡聚物,以及它们治疗疾病的用途
|
EP2152889B1
(en)
|
2007-05-29 |
2017-03-15 |
Nature Technology Corporation |
Vectors and methods for genetic immunization
|
TR201000668T1
(tr)
|
2007-07-31 |
2010-06-21 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Neoplasti̇k veya enfeksi̇yoz bozukluklara yöneli̇k i̇mmunoprofi̇laksi̇ veya i̇mmünoterapi̇ i̇çi̇n poli̇pepti̇d-nüklei̇k asi̇t konjugati
|
US8367815B2
(en)
|
2007-08-28 |
2013-02-05 |
California Institute Of Technology |
Modular polynucleotides for ligand-controlled regulatory systems
|
WO2009038707A2
(en)
|
2007-09-17 |
2009-03-26 |
Ludwig Institute For Cancer Research , Ltd. |
Cancer-testis gene silencing agents and uses thereof
|
CA2702217A1
(en)
|
2007-10-11 |
2009-04-16 |
Jayne Danska |
Modulation of sirp.alpha. - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
|
CA2702039A1
(en)
|
2007-10-12 |
2009-04-23 |
Intradigm Corporation |
Therapeutic sirna molecules for reducing vegfr1 expression in vitro and in vivo
|
DE102007052114B4
(de)
|
2007-10-30 |
2011-01-05 |
T2Cure Gmbh |
Verfahren zur Modulation der Funktion, des Wachstums oder der Differenzierung einer Zelle
|
WO2009060124A2
(en)
|
2007-11-05 |
2009-05-14 |
Baltic Technology Development, Ltd. |
Use of oligonucleotides with modified bases in hybridization of nucleic acids
|
EP2207787B1
(en)
|
2007-11-06 |
2014-11-12 |
AdiuTide Pharmaceuticals GmbH |
Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
|
USRE46873E1
(en)
|
2007-11-06 |
2018-05-29 |
Sirnaomics, Inc. |
Multi-targeted RNAi therapeutics for scarless wound healing of skin
|
EP2217706B1
(en)
|
2007-11-12 |
2015-05-27 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
|
US8357501B2
(en)
|
2007-11-29 |
2013-01-22 |
Molecular Health Gmbh |
Tissue protective erythropoietin receptor (NEPOR) and methods of use
|
ES2542033T3
(es)
|
2007-11-29 |
2015-07-29 |
Molecular Health Gmbh |
Receptor de eritropoyetina protector de tejido (NEPOR) y métodos de uso
|
GB0725321D0
(en)
|
2007-12-31 |
2008-02-06 |
Syntaxin Ltd |
Delivery vehicles
|
EP3346005A1
(en)
|
2008-01-31 |
2018-07-11 |
CureVac AG |
Nucleic acids of formula (i) (nuglxmgnnv)a and derivatives thereof as an immunostimulating agent/adjuvant
|
US9738680B2
(en)
*
|
2008-05-21 |
2017-08-22 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
5′ triphosphate oligonucleotide with blunt end and uses thereof
|
PL2518150T3
(pl)
|
2008-05-21 |
2016-02-29 |
Univ Bonn Rheinische Friedrich Wilhelms |
Oligonukleotyd 5' trifosforanowy z tępym końcem i jego zastosowania
|
CA2635187A1
(en)
|
2008-06-05 |
2009-12-05 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Oligonucleotide duplexes and uses thereof
|
US20110152352A1
(en)
|
2008-06-10 |
2011-06-23 |
Tufts University |
Smad proteins control drosha-mediated mirna maturation
|
CN101632833B
(zh)
|
2008-07-25 |
2013-11-06 |
上海市计划生育科学研究所 |
一种***癌相关的基因及其用途
|
AU2009288078B2
(en)
*
|
2008-09-02 |
2014-10-30 |
Alnylam Pharmaceuticals, Inc. |
Synthetic methods and derivatives of triphosphate oligonucleotides
|
WO2011028218A1
(en)
*
|
2009-09-02 |
2011-03-10 |
Alnylam Pharmaceuticals, Inc. |
Process for triphosphate oligonucleotide synthesis
|
WO2010042742A2
(en)
|
2008-10-08 |
2010-04-15 |
Chimeros Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
WO2010042755A2
(en)
|
2008-10-08 |
2010-04-15 |
Chimeros Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
WO2010042749A2
(en)
|
2008-10-08 |
2010-04-15 |
Chimeros Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
WO2010042751A2
(en)
|
2008-10-08 |
2010-04-15 |
Chimeros Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
JP4936343B6
(ja)
|
2008-10-23 |
2018-06-27 |
国立大学法人 東京大学 |
microRNAの機能阻害法
|
WO2010062502A1
(en)
|
2008-11-03 |
2010-06-03 |
University Of Utah Research Foundation |
Carriers for the delivery of nucleic acids to cells and methods of use thereof
|
JP2012518997A
(ja)
|
2009-02-26 |
2012-08-23 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
喫煙未経験者におけるマイクロrna、ならびに関連する材料および方法
|
WO2010118263A1
(en)
|
2009-04-08 |
2010-10-14 |
University Of Massachusetts |
Single-nucleotide polymorphism (snp) targeting therapies for the treatment of huntington's disease
|
WO2010120874A2
(en)
|
2009-04-14 |
2010-10-21 |
Chimeros, Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
US20100323018A1
(en)
|
2009-06-17 |
2010-12-23 |
Massachusetts Institute Of Technology |
Branched DNA/RNA monomers and uses thereof
|
ES2386855T3
(es)
|
2009-07-09 |
2012-09-03 |
Marina Biotech, Inc. |
Emulación de estructuras de lipoproteínas
|
US9238811B2
(en)
|
2009-07-14 |
2016-01-19 |
Northeastern University |
siRNA phospholipid conjugate
|
WO2011011716A1
(en)
|
2009-07-23 |
2011-01-27 |
The Trustees Of Princeton University |
Inhibitors of mtor kinase as anti-viral agents
|
WO2011028128A1
(en)
*
|
2009-09-01 |
2011-03-10 |
Askim Frukt- Og Bærpresseri As |
Method to prevent oxidation of components in oil, and method to reduce the use of ethoxyquin to prevent oxidation of components in oil
|
EP2327783A1
(en)
|
2009-11-27 |
2011-06-01 |
Universitätsklinikum Freiburg |
Pharmaceutical composition comprising miRNA-100 and its use in the modulation of blood vessel growth
|
DE202009015670U1
(de)
|
2009-11-30 |
2011-04-14 |
Mcairlaid's Vliesstoffe Gmbh & Co. Kg |
Absorptionskörper zur Auflage auf Wunden
|
US20110247091A1
(en)
|
2010-03-26 |
2011-10-06 |
The Governors Of The University Of Alberta |
Transgenic Cells and Chickens Expressing RIG-I
|
WO2011133559A2
(en)
|
2010-04-19 |
2011-10-27 |
University Of Georgia Research Foundation, Inc. |
Alpha tubulin acetyltransferase
|
EP2385120A1
(en)
|
2010-05-04 |
2011-11-09 |
Justus-Liebig- Universitat Giessen |
Use of anti-miRNA antisense oligonucleotides for the treatment of pulmonary hypertension
|
US9642873B2
(en)
|
2010-05-04 |
2017-05-09 |
Sirnaomics, Inc. |
Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic application
|
CN101974529B
(zh)
|
2010-09-21 |
2013-04-03 |
南京大学(苏州)高新技术研究院 |
含自由三磷酸基团的TGF-β特异性siRNA及其应用
|
WO2012056440A1
(en)
|
2010-10-28 |
2012-05-03 |
Nanodoc Ltd. |
COMPOSITIONS AND METHODS FOR ACTIVATING EXPRESSION BY A SPECIFIC ENDOGENOUS miRNA
|
WO2012056441A1
(en)
|
2010-10-28 |
2012-05-03 |
Nanodoc Ltd. |
Compositions and methods for specific cleavage of exogenous rna in a cell
|
CN102475892A
(zh)
|
2010-11-22 |
2012-05-30 |
大连创达技术交易市场有限公司 |
作为制备抗癌药物的反义miRNA-210的用途
|
CA2823182C
(en)
|
2010-12-30 |
2016-02-23 |
Samyang Biopharmaceuticals Corporation |
Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
|
US8461224B2
(en)
|
2011-03-04 |
2013-06-11 |
National Health Research Institutes |
Single monomer derived linear-like copolymer comprising polyethylenimine and poly(ethylene glycol) for nucleic acid delivery
|
WO2012125987A2
(en)
|
2011-03-17 |
2012-09-20 |
Massachusetts Institute Of Technology |
Delivery system
|
EP2508530A1
(en)
*
|
2011-03-28 |
2012-10-10 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Purification of triphosphorylated oligonucleotides using capture tags
|
EP2729182A4
(en)
|
2011-07-04 |
2014-12-24 |
Commw Scient Ind Res Org |
NUCLEIC COMPLEX
|
EP2551354A1
(en)
|
2011-07-25 |
2013-01-30 |
Universität Heidelberg |
Functionalization of RNA oligonucleotides
|
US20130189367A1
(en)
|
2011-07-29 |
2013-07-25 |
University Of Washington Through Its Center For Commercialization |
Nanovectors for targeted gene silencing and cytotoxic effect in cancer cells
|
US9579394B2
(en)
|
2011-08-08 |
2017-02-28 |
Universitaet Regensburg |
Polyanion nanocomplexes for therapeutic applications
|
EP2765982A1
(de)
|
2011-10-11 |
2014-08-20 |
Hans Kosak |
Dimethylsulfoxid als lösungsmittel für nukleinsäuren
|
WO2013053480A1
(de)
|
2011-10-11 |
2013-04-18 |
Secutech International Pte. Ltd. |
Zusammensetzung zur einbringung von nukleinsäuren in zellen
|
EP2773760B2
(en)
|
2011-10-31 |
2020-11-04 |
RiboxX GmbH |
Double-stranded rna for immunostimulation
|
US9631192B2
(en)
|
2011-11-17 |
2017-04-25 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Auto-recognizing therapeutic RNA/DNA chimeric nanoparticles (NP)
|
JP2015518475A
(ja)
|
2012-04-10 |
2015-07-02 |
インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラルシェルシェ メディカル)Inserm(Institut National Dela Sante Etde La Recherche Medicale) |
非アルコール性脂肪性肝炎の治療方法
|
US20130302252A1
(en)
|
2012-05-11 |
2013-11-14 |
University Of Washington Through Its Center For Commercialization |
Polyarginine-coated magnetic nanovector and methods of use thereof
|
EP2712870A1
(en)
|
2012-09-27 |
2014-04-02 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Novel RIG-I ligands and methods for producing them
|
US20140287023A1
(en)
|
2013-02-11 |
2014-09-25 |
Mcgill University |
5'-triphosphate oligoribonucleotides
|